TRLV Got Rejected at Its 52-Week High After a 29% Melt-Up—$12.45 Decides Whether the Rally Dies

Trulieve Cannabis (NYSE: TRLV) ran nearly 30% in a month, thrust into its 52-week high, and got slapped back 5% on the way up. The question is whether today is a pause in a breakout or the moment the momentum crowd gets trapped.

Trulieve spent a month doing what cannabis stocks are supposed to do after a big rule change: it went straight up. The stock gained roughly 29% over the past twenty sessions, carrying it from the low $9s toward a retest of the $12.76 high it has not touched in a year. This morning it reached $12.45 intraday, still shy of that ceiling—and immediately reversed. As of early trading on September 10, TRLV sits at $11.77, down 5.3%, with a day's range of $11.62 to $12.45.

That is not a quiet drift lower. The reversal is landing on elevated volume—about 2.3 million shares against a ~1.24 million average—and the order flow is seller-dominated across every size bucket: large, medium, and retail orders all show more flow going out than in. The move up was real participation; the rejection is real distribution. That combination, at the top of a parabolic run, is exactly where a momentum story either reloads or ends.

Why the run happened—and why it may not hold

The fuel is well documented. Trulieve became the first U.S. cannabis company to list on the NYSE in June 2026, after the Department of Justice issued a final rule moving marijuana to Schedule III. That is the event that unlocks what the trade has always been about: plant-touching operators finally getting access to major-exchange liquidity and, in theory, mainstream institutional capital. Trulieve rang the closing bell in August to celebrate the listing.

The company's own results are solid but not the point of the move. In the second quarter it posted revenue of $271 million with a 60% gross margin, and adjusted earnings of $0.11 per share beat the $0.08 consensus—though revenue came in a hair below the $272 million forecast. First-half operating cash flow was $109 million. This is a profitable-margin, cash-generating operator; it is not a company with weak numbers.

But it is also not a company whose current financials justify a 29% month. On a trailing basis earnings are negative, and the rally is being priced on a regulatory and positioning story: Schedule III access, institutional sponsorship, and the hope that more upside unlocks. That is precisely the kind of multiple that has no earnings floor beneath it. When momentum is the thesis, the chart is the only safety net—and today the chart just refused the high.

The line that changes the odds

Everything now runs through $12.45, today's rejection point, with the $12.76 52-week high as the objective beyond it.

The level has memory, not just a round-number look. $12.76 is the high this stock has failed to convert into new ground for a year. The more obvious a ceiling becomes, the more sellers and options interest cluster on top of it—which is why price went from $12.45 straight back to $11.77 in a single session. Someone was waiting there with size.

On the other side, $11.62 is today's low and the first line that decides whether this is a healthy shakeout or a failed breakout. Below that, the chart does not offer much until the $11 round number and the zone where the run actually launched near $9–10. A decisive break of $11.62 with volume converts the buyers who chased the melt-up into trapped inventory, and the air pocket below is a long fall with no earnings multiple to catch it.

What the tape is saying

The cleanest read: this is a high-volatility decision point, not yet a crash. Trulieve's daily volatility runs near 6–7%, and its average true range is about $0.67—so a 5% day is uncomfortable but normal motion for this name. The signal is not the size of the drop; it is the location. Getting rejected under the 52-week high, on rising volume, with sellers leading every order size, is the chart's way of saying the marginal buyer who powered the 29% run stepped aside at the worst possible price for late arrivals.

For a breakout buyer, the setup is a reclaim: TRLV needs to take back $12.45 and then clear $12.76 on expanding volume for new highs to be real. For anyone watching a pullback, the discipline is the border at $11.62. Hold that and the uptrend gets to retest the ceiling; lose it and today's rejection becomes the top of a distribution pattern, not a pause.

The verdict

Reclaim $12.45 and clear $12.76—the 29% momentum story resumes and the year-old ceiling becomes support. Lose $11.62 on volume, and the buyers who chased the melt-up are trapped, with the chart offering little support until the $11 round number and the launch zone below.

The stock has momentum and a genuine catalyst behind it. But the catalyst is already priced into a 29% month, and a stock that rises on hope and positioning falls on the same graph when the marginal buyer stops paying up. Today, at $11.77, that is the entire contest: $12.45 or $11.62—whichever gives first decides whether this is a breakout or a blow-off.

Data as of early trading September 10, 2026, New York time. Technical observations are for analysis, not personalized investment advice.